Samorita Hospital Limited announcements
287 Dhaka Stock Exchange announcements for Samorita Hospital Limited (SAMORITA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (21).
- Resumption after record date
Trading of the shares of the Company will resume on 01.12.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 30.11.2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 28.11.2022 to 29.11.2022. Trading of the shares of the Company will remain suspended on record date i.e., 30.11.2022.
- Credit Rating Agency of Bangladesh Limited (CRAB) has announced the Entity Rating of the Company as \"A3\" in the long t
Credit Rating Agency of Bangladesh Limited (CRAB) has announced the Entity Rating of the Company as \"A3\" in the long term along with a Stable outlook based on audited financial statements up to June 30, 2022; bank liability position as on November 14, 2022, and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- The Board of Directors has recommended 5\% cash and 5\% Stock dividend for the year ended June 30, 2022. Date of AGM: 26
The Board of Directors has recommended 5\% cash and 5\% Stock dividend for the year ended June 30, 2022. Date of AGM: 26.12.2022, Time: 11:00 AM, Venue: Digital Platform. Record date: 30.11.2022. The Company has also reported EPS of Tk. 0.86, NAV per share of Tk. 51.32 and NOCFPS of Tk. 1.85 for the year ended June 30, 2022 as against Tk. 2.23, Tk. 51.46 and Tk. 3.18 respectively for the same period of the previous year. (cont.1)
- (Continuation news of SAMORITA): The Company has also informed that a) Bonus shares have been recommended out of the ret
(Continuation news of SAMORITA): The Company has also informed that a) Bonus shares have been recommended out of the retained amount of the company as capital for better working capital management of the company; b) Bonus shares are declared out of accumulated profit of the company; c) Bonus shares have not been declared from capital reserve or revaluation reserve or any unrealized gain or out of profit earned (cont.2)
The first part of this announcement is missing from the archive. - (Q1 Un-audited): EPS was Tk. 0.15 for July-September 2022 as against Tk. 1.08 for July-September 2021; NOCFPS was Tk. 0.
(Q1 Un-audited): EPS was Tk. 0.15 for July-September 2022 as against Tk. 1.08 for July-September 2021; NOCFPS was Tk. 0.93 for July-September 2022 as against Tk. 1.57 for July-September 2021. NAV per share was Tk. 51.47 as on September 30, 2022 and Tk. 51.32 as on June 30, 2022. (cont.1)
- (Continuation news of SAMORITA): Reasons for significant deviation: Operating result in the reporting period has been si
(Continuation news of SAMORITA): Reasons for significant deviation: Operating result in the reporting period has been significantly decreased due to the following reasons: a) Revenue has been decreased by Tk. 3.70 Crore. b) Cost of direct materials has been increased by 1.08 \%. (cont.2)
The first part of this announcement is missing from the archive. - The auditor of the Samorita Hospital Limited has given the \"Qualified Opinion\" paragraphs in the auditor\'s report for
The auditor of the Samorita Hospital Limited has given the \"Qualified Opinion\" paragraphs in the auditor\'s report for the year ended June 30, 2022. Basis for Qualified Opinion: The entity revalued its Land in 2013. However, as per Para-34, of IAS-16 it should be revalued within three to five years. Hence the entity non-comply with the said standard.
- Q1 Financials
(Continuation news of SAMORITA): c) Administrative expenses have been increased from 37.65% to 55.52% of revenue. Net operating cash flow per share (NOCFPS) decreased from Tk. 1.57 to Tk.0.93 due to Cash receipts from Customers have been decreased by Tk. 3.03 Crore. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (09.11.2022) following its corporate declaration. However, as per the BSEC Order No. BSEC/CMRRCD/2001-07/39 dated July 28, 2022, the floor price shall be applicable accordingly.
- Dividend Declaration
(Continuation news of SAMORITA): prior to incorporation of the Company or through reducing paid up capital or through doing anything so that the post-dividend retained earnings become negative or a debit balance. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 08, 2022 at 7:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 08, 2022 at 7:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.01 for January-March 2022 as against Tk. 0.23 for January-March 2021; EPS was Tk. 1.27 for July 2021-March 2022 as against Tk. 1.58 for July 2020-March 2021. NOCFPS was Tk. 2.03 for July 2021-March 2022 as against Tk. 2.88 for July 2020-March 2021. NAV per share was Tk. 51.73 as on March 31, 2022 and Tk. 51.46 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the company has informed that a meeting of the Board of Directors will be held on April 23, 2022 at 2:00 PM to consider, among others, un-audited financial statements of the company for the Third Quarter (Q3) period ended March 31, 2022.
- (Q2 Un-audited): EPS was Tk. 0.18 for October-December 2021 as against Tk. 1.01 for October-December 2020, EPS was Tk. 1
(Q2 Un-audited): EPS was Tk. 0.18 for October-December 2021 as against Tk. 1.01 for October-December 2020, EPS was Tk. 1.26 for July-December 2021 as against Tk. 1.35 for July-December 2020. NOCFPS was Tk. 1.90 for July-December 2021 as against Tk. 2.47 for July-December 2020. NAV per share was Tk. 51.72 as on December 31, 2021 and Tk. 51.46 as on June 30, 2021. (Cont. 1)
- (Continuation news of SAMORITA): The Company has also informed that reasons of deviation in financial parameters: Operat
(Continuation news of SAMORITA): The Company has also informed that reasons of deviation in financial parameters: Operating result in the reporting period has been decreased due to the following reasons, compared to previous corresponding period: a) Revenue has been decreased by Tk. 1.37 Crore. B) Cost of direct materials has been increased from 41.29\% to 41.58\%. c) Administrative expenses have been increased from 42.57\% to 43.03\% of revenue. (Cont. 2)
The first part of this announcement is missing from the archive. - Q2 Financials
(Continuation news of SAMORITA): Net operating cash flow per share (NOCFPS) decreased due to the following reasons: a) Cash Received from Customers has been decreased by Tk. 1.18 Crore and b) Income Tax Paid has been increased by Tk. 28.00 lac. (end)
The first part of this announcement is missing from the archive. - Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2021 to the respective shareholders.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2022 at 11:00 AM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2021.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.